Caris Life Sciences, Inc. CAI ← Back to all reports

Caris Life Sciences, Inc.

CAI · Healthcare
C ★★ Sell
Nov 7, 2026 · Score 60 · Type B — Growth-style analysis Used for higher-growth companies — weighs revenue trajectory, total addressable market (TAM) expansion, and forward-looking multiples. Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology → $25.23

Type B - Caris Life Sciences, Inc. (CAI) 20261107 Stock Analysis

📅 Caris Life Sciences Key Upcoming Events

🏢 Step 1: Caris Life Sciences Company Overview & Business Model

Q1-A1. What is Caris Life Sciences?

Q1-A2. How Does Caris Life Sciences Make Money?

Q1-A3. Caris Life Sciences’s Revenue Segments & Core Income Sources

Q1-A4. Who Are Caris Life Sciences’s Competitors?

Q1-A5. What Problem Does Caris Life Sciences Solve?

Q1-A6. Caris Life Sciences Key Milestones: Past 12 Months

Q1-A7. Step 1 Key Takeaways

🌲 Step 2: Caris Life Sciences’s , Market Size & Scalability

Q2-A1. Does Caris Life Sciences Have a Durable Economic Moat?

Q2-A2. How Big Is Caris Life Sciences’s Market? ()

Q2-A3. How Real Is Caris Life Sciences’s TAM? (Quality Check)

Q2-A4. Can Caris Life Sciences Keep Expanding Its Market?

Q2-A5. Step 2 Key Takeaways

🚀 Step 3: How Fast Is Caris Life Sciences Growing? Hyper-Growth Metrics

Q3-A1. How Fast Is Caris Life Sciences Growing? (Revenue Trajectory)

Q3-A2. Caris Life Sciences’s Key Growth Metrics

Q3-A3. Are Caris Life Sciences’s Unit Economics Improving?

Q3-A4. Step 3 Key Takeaways

💪 Step 4: Caris Life Sciences’s Profit Potential &

Q4-A1. Can Caris Life Sciences Turn Growth Into Profit?

Q4-A2. Does Caris Life Sciences Generate Free Cash Flow?

Q4-A3. Step 4 Key Takeaways

👔 Step 5: Caris Life Sciences Management & Shareholder Alignment

Q5-A1. Who Leads Caris Life Sciences? (Founder & Management)

Q5-A2. Is Caris Life Sciences’s Management Aligned With Shareholders?

Q5-A3. Step 5 Key Takeaways

⛵ Step 6: Caris Life Sciences Market Flow & Sentiment

Q6-A1. vs Caris Life Sciences Guidance

Q6-A2. What Is Caris Life Sciences’s ?

Q6-A3. Step 6 Key Takeaways

🧨 Step 7: Caris Life Sciences Catalysts & Price Triggers

Q7-A1. What Could Re-Rate Caris Life Sciences Stock? (Next 12 Months)

Q7-A2. Caris Life Sciences’s Estimate Revision Trend

Q7-A3. Step 7 Key Takeaways

⚖️ Step 8: Is Caris Life Sciences Fairly Valued? Valuation Analysis

Q8-A1. Caris Life Sciences’s Key Valuation Multiples

Q8-A2. Caris Life Sciences vs Peers: Valuation Comparison

Q8-A3. What Is Caris Life Sciences Worth in the Future? (Forward Valuation)

Q8-A3-1. What Growth Hurdle Does the Market Demand From Caris Life Sciences? (Forward Valuation Alternative)

Q8-A4. Final Valuation Adjustment

Q8-A5. Valuation Adjustment Score Calculation

💀 Step 9: What Are the Risks of Caris Life Sciences? Fatal Risks & Pre-Mortem

Q9-A1. Is Caris Life Sciences Burning Cash & Diluting Shareholders?

Q9-A2. Do Competition or Regulation Threaten Caris Life Sciences?

Q9-A3. Caris Life Sciences Pre-Mortem: What Could Go Wrong?

Q9-A4. Risk Adjustment Score

🎯 Step 10: Caris Life Sciences Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

Q10-A2. Should You Buy Caris Life Sciences? (Recommendation)

Q10-A3. Investment Thesis in One Line

Q10-A4. Caris Life Sciences’s Price Trend & Key Drivers

Q10-A5. Action Plan

🕵️‍♂️ Deep Dive Analysis

Rating History

Rating History shows the Rating assigned on each report date. Only the latest report is available to read. Scores are omitted from the timeline because reports from different periods may follow different rating scales.

  1. 2026-07 S
  2. 2026-08 A
  3. 2026-11 C